[BRAF mutation detection in metastatic melanoma]

MeSH terms

• Antineoplastic Agents / adverse effects
• Antineoplastic Agents / therapeutic use
• Clinical Trials, Phase III as Topic
• Combined Modality Therapy
• DNA Mutational Analysis*
• Germany
• Humans
• Indoles / adverse effects
• Indoles / therapeutic use
• Lymph Nodes / pathology
• Lymphatic Metastasis / pathology
• Melanoma / drug therapy
• Melanoma / genetics*
• Melanoma / pathology
• Melanoma / secondary*
• Molecular Targeted Therapy
• Proto-Oncogene Proteins B-raf / antagonists & inhibitors
• Proto-Oncogene Proteins B-raf / genetics*
• Quality Control
• Randomized Controlled Trials as Topic
• Real-Time Polymerase Chain Reaction
• Skin Neoplasms / drug therapy
• Skin Neoplasms / genetics*
• Skin Neoplasms / pathology
• Sulfonamides / adverse effects
• Sulfonamides / therapeutic use
• Vemurafenib